AI assistant
AGENUS INC — Director's Dealing 2014
Jan 6, 2014
34023_dirs_2014-01-06_7e01d858-d3f5-4d8e-91c0-a9ae15744012.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AGENUS INC (agen)
CIK: 0001098972
Period of Report: 2014-01-02
Reporting Person: ARMEN GARO H (Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-01-02 | Common Stock | J | 5041 | $2.6181 | Acquired | 1618611 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Sotck | 43900 | Indirect |
Footnotes
F1: Represents issuance of stock for payment of 33% of Dr. Armen's base salary for December 2013.
F2: Dr. Armen is trustee and has investment authority for the Garo Armen 2012 2 Year GRAT holding 39,854 shares of Agenus Inc. common stock. Dr. Armen disclaims beneficial ownership therein. Dr. Armen is also Chairman of the Board of Managers and a member of Antigenics Holdings LLC ("Holdings") which as of the date of this report owns 4,046 shares of Agenus Inc. common stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Holdings and disclaims beneficial ownership of this pecuniary interest therein.